Skip to main content

Biovie Inc.

BIVI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001580149

In the last 90 days, Biovie Inc. insiders filed 4 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $2.86M in total; no superinvestor holds it.

Other share classesBIVIW

Holders of 5% or more of BIVI

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Biovie Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of BIVI
HolderLatest formStakeChangeFirst filedLatest filingFiling
Acuitas Group Holdings, LLC13D/A15.80%3.05M shares–Jun 30, 20251 filingJun 30, 2025SEC
Alta Partners LLC13G8.40%687.3K sharesNewAug 19, 20261 filingAug 19, 2026SEC
Jane Street Group, LLC13G5.20%441.8K sharesNewSep 3, 20261 filingSep 3, 2026SEC
Do Cuong V13D5.03%399.0K sharesNewMar 25, 20261 filingMar 25, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

5 Schedule 13D and 13G filings on Biovie Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on BIVI
Filed (ET)FilerFormStakeChangeEvent dateFiling
Sep 3, 20264:03 PM ETJane Street Group, LLCand 2 others13G5.20%441.8K sharesNewAug 28, 2026SEC
Aug 19, 20264:08 PM ETAlta Partners LLC13G8.40%687.3K sharesNewAug 12, 2026SEC
Mar 25, 20265:00 PM ETDo Cuong Vand 1 other13D5.03%399.0K sharesNewJan 5, 2026SEC
Jun 30, 20258:35 PM ETAcuitas Group Holdings, LLCand 1 other13D/A15.80%3.05M shares–Jun 25, 2025SEC
Feb 11, 20256:07 PM ET3i, LPand 2 others13G/A0.00%0 shares–Below 5%Dec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Biovie Inc. shares.

No Form 144 notices for Biovie Inc. are on file.